A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With Hyperphosphatemia

Sponsors and Collaborators
Kissei Pharmaceutical Co., Ltd.

Contact
Kissei Pharmaceutical Co., Ltd
rinsyousiken@pharm.kissei.co.jp

ClinicalTrials.gov Identifier
NCT01850641